Resolution of Inflammation: What Controls Its Onset?

Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. · 2016

Read Resolution of Inflammation: What Controls Its Onset? by Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4845539.txt.

Description

Michelle A. Sugimoto and four co-authors reviewed what starts the shut-down phase of inflammation, in Frontiers in Immunology in 2016. Inflammation that never resolves can harden into chronic disease. The review stresses that the shut-down program is active, planned, and begins soon after inflammation starts, not after it fades. Signals that drive the attack phase can also switch on the cleanup.

Key steps include falling levels of the signals that call in neutrophils, the first-responder white cells. Those same neutrophils, though attack cells, also help trigger resolution. Mapping these start signals could yield drugs that push the body to finish inflammation cleanly, a field the review calls resolution pharmacology.

Catalog record

CREATORSugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE116 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4845539

Browse the full library · About the Tower of Babel